We invite authors to submit abstracts to advance the knowledge, skills, and competence of physicians in the identification, diagnosis, treatment, and management of neuromuscular diseases. Cases will be discussed with the goal of identifying the diagnosis during the live presentation, as part of the learning activity. As such, we request that final diagnosis is omitted from the abstract title.

ABSTRACT SUBMISSION:

  • All are welcome to submit abstracts. Acceptance will be based entirely upon quality.
  • Abstract is not to exceed 300 words and must be submitted in electronic form
  • Cases will be discussed with the goal of identifying the diagnosis during the live presentation, as part of the learning activity. As such, we ask that the final diagnosis be omitted from the abstract title and the body of the abstract.¬†
  • Spell out all abbreviated terms at first use. If many abbreviations are used, attach a separate sheet listing the spelled out abbreviations. (Abstracts without the full spellings of abbreviations will be returned)
  • Reference citations must provide the name of first author, the title of book or name of journal and year published. All authors must be provided when submitting an abstract. No changes can be made after submission.
  • Do not include a continuation page, illustrations, or tables.
  • Abstracts must report work not presented or published prior to the meeting.
  • Video clips must be less than one minute.

ACCEPTED ABSTRACTS:

  • Authors of accepted abstracts will be notified by December 20, 2017.
  • The time allowed for presentations from the platform and posters may vary according to the material presented and the needs of the session. Authors will be notified by the course director.
  • Accepted abstracts will be printed in the Journal of Clinical Neuromuscular Disease.

DISCLOSURES:

  • It is the policy of ACCME that all persons in the position to control the content of an educational activity are required to disclose all relevant financial relationships in any amount occurring within the past 12 months with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients. A primary mechanism to resolve identified conflicts of interest is a content review that is prior to the activity.
  • A completed disclosure form must be uploaded for each author listed on abstract submission form at the time of submission. This form is available for download.

Conflict of Interest Disclosure Form (PDF)

REGISTRATION FOR SYMPOSIUM:

  • All speakers must register for the symposium on their own.